Recent advances have greatly improved our understanding of the molecular mechanisms
behind atherosclerosis pathogenesis. However, there is still a need to systematize this data …

Recent clinical trials have now firmly established that inflammation participates causally in
human atherosclerosis. These observations point the way toward novel treatments that add …

Atherosclerosis (AS) is widespread and develops into circulatory system problems. T cells
play an essential regulatory role in AS occurrence and development. So far, there is no …

Type 2 diabetes mellitus (T2DM) affects the formation of carotid atherosclerotic plaques
(CAPs) and patients are prone to plaque instability. It is crucial to clarify transcriptomics …

Atherosclerosis and its complications are a major cause of morbidity and mortality worldwide
in spite of the improved medical and invasive treatment in terms of revascularization …

Atherosclerosis is a common cardiovascular disease caused by the abnormal expression of
multiple factors and genes influenced by both environmental and genetic factors. The …

Atherosclerosis is a chronic inflammatory disease of the vascular system that is
characterized by the deposition of modified lipoproteins, accumulation of immune cells, and …

In the genesis and progression of cardiovascular diseases involving both innate and
adaptive immune responses, inflammation plays a pivotal and dual role. Studies in …

Atherosclerosis is the major cause of the development of cardiovascular disease, which, in
turn, is one of the leading causes of mortality worldwide. From the point of view of …

Atherosclerosis (AS) is a chronic inflammatory disease caused by disorders of lipid
metabolism. Abnormal deposition of low-density lipoproteins in the arterial wall stimulates …